EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Q-linea AB's enterprise value is kr226.09 Mil.
Q-linea AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was kr-210.29 Mil. Therefore, Q-linea AB's EV-to-EBITDA for today is -1.08.
The historical rank and industry rank for Q-linea AB's EV-to-EBITDA or its related term are showing as below:
OSTO:QLINEA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -21.08 Med: -8.33 Max: 0.24
Current: -1.08
During the past 9 years, the highest EV-to-EBITDA of Q-linea AB was 0.24. The lowest was -21.08. And the median was -8.33.
OSTO:QLINEA's EV-to-EBITDA is ranked worse than 100% of 484
companies
in the Medical Devices & Instruments industry
Industry Median: 16.065
vs OSTO:QLINEA: -1.08
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-05), Q-linea AB's stock price is kr2.46.
Q-linea AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-5.354. Therefore, Q-linea AB's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Q-linea AB EV-to-EBITDA Historical Data
The historical data trend for Q-linea AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Q-linea AB's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, Q-linea AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-linea AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Q-linea AB's EV-to-EBITDA falls into.
Q-linea AB EV-to-EBITDA Calculation
Q-linea AB's EV-to-EBITDA for today is calculated as:
Q-linea AB's current Enterprise Value is kr226.09 Mil.
Q-linea AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-210.29 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-linea AB (OSTO:QLINEA) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Q-linea AB's share price for today is kr2.46.
Q-linea AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-5.354.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Q-linea AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Q-linea AB is a company that develops solutions for improved infectious disease diagnostics. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:QLINEA has been successfully added to your 